✦ LIBER ✦

Digoxin Use and Heart Failure Outcomes: Results from the Valsartan Heart Failure Trial (Val-HeFT)

✍ Scribed by Javed Butler; Inder S. Anand; Michael A. Kuskowski; Thomas Rector; Peter Carson; Jay N. Cohn; for the Val-HeFT Investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multinational economic evaluation of val

✍ Shelby D Reed; Joëlle Y Friedman; Eric J Velazquez; Ari Gnanasakthy; Robert M Ca 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Valsartan Reduces the Incidence of Atria

✍ A.P. Maggioni; R. Latini; P.E. Carson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Valsartan reduces the incidence of atria

✍ Aldo P. Maggioni; Roberto Latini; Peter E. Carson; Steven N. Singh; Simona Barle 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Lessons learned from the Valsartan- Hear

✍ Jay N Cohn 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 37 KB

The benefits of valsartan in the treatme

✍ L-B Tan; D. Schlosshan; S. G. Williams 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Effects of valsartan on circulating brai

✍ R. Latini; S. Masson; I. Anand 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 36 KB